This trust offers the following services:

• Acute services:
• On-site bowel stenting facilities

• Diagnostic and pre-operative services:
• On-site PET-CT facilities
• On-site Cardio-Pulmonary Exercise Testing (CPET) facilities
• Routine Genetic Testing for Lynch Syndrome

• Surgical services:
• On-site hepatobiliary surgical team
• On-site thoracic surgical team
• Robotic surgery

• Advanced disease services:
• Dedicated Specialist Advanced Nurse
• Dedicated Specialist Advanced MDT
• Dedicated Specialist Advanced Outpatient Clinic
• Complex vascular reconstruction
• Distal sacrectomy
• Extended lymphadenectomy

• Support service facilities:
• Dedicated nurses for ERAS services
• Availability of 24 hour palliative care advice
• 7-day access to face-to-face palliative care services

All Patients:	Trust	Network	National
Number of patients in Audit	409	3482	35779
Case ascertainment (%)	Fair	Good	Good
Data completeness of:
– Pre-treatment TNM (%)	85	83	86
– Performance status (%)	90	90	89

Patients having major resection:	Trust	Network	National
Number of patients in Audit	308	2135	19631
ASA grade 1 (%)	4	5	9
ASA grade 2 (%)	46	53	53
ASA grade 3 (%)	45	34	31
ASA grade 4+ (%)	4	4	2
ASA grade not recorded (%)	1	4	4
Data completeness of:
7 Audit items for risk-adjustment (%)	92	87	87

All Patients:	Trust	Network	National
Number of patients in Audit	409	3482	35779
Seen by Clinical Nurse Specialist (%)	100	89	88

Patients having major resection:	Trust	Network	National
Number of patients in Audit	308	2135	19614
Distant metastases (%)	2	4	5
Urgent or emergency surgery (%)	8	24	15
At least 12 lymph nodes excised (%)	81	82	84
Laparoscopic surgery attempted (%)	62	72	72
Risk-adjusted length of stay > 5 days (%)	44	49	55

Patients having major resection for stage III colon cancer:	Trust	Network	National
Number of patients in audit	147	N/A	10747
Adjuvant chemotherapy (%)	70	N/A	62

Patients receiving chemotherapy after major resection for stage III colon cancer:	Trust	Network	National
Number of patients in audit	103	N/A	6608
Severe acute toxicity after adjuvant chemotherapy (%)	23	N/A	22

Patients having major resection:	Trust	Network	National
Number of patients in Audit	64	N/A	4251
Neoadjuvant therapy (%)	48	N/A	33
Circumferential resection margin: Recorded (%)	95	88	89
Circumferential resection margin: Negative (%)	83	81	83
Rectal volume	65	N/A	4377

Patients in APER/Hartmanns estimate:	Trust	Network	National
Number of patients in APER/Hartmanns estimate	247	2273	19644
APER/Hartmanns (%)	48	38	37